CTT Pharma Corporate UpdatesTheNewswire · Sep 16, 2026
CTT Pharma Files a Patent Continuation with the U.S. Patent OfficeTheNewswire · Aug 18, 2026
CTT Pharma Corporate UpdatesTheNewswire · Aug 12, 2026
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery TechnologyTheNewswire · Aug 10, 2026
CTT Pharma Receives SEC ApprovalTheNewswire · Aug 5, 2026CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.